Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies.

Autor: Dilcher R; Neuroscience, Monash University, Melbourne, Australia.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Wall S; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Groß M; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, München, Germany., Katzdobler S; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Wagemann O; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany., Palleis C; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Weidinger E; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany., Fietzek U; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany., Bernhardt A; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Kurz C; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, München, Germany., Ferschmann C; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Scheifele M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Zaganjori M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, München, Germany., Gnörich J; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Bürger K; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Janowitz D; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, München, Germany., Rauchmann BS; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, München, Germany.; Institute for Neuroradiology, University Hospital of Munich, LMU Munich, München, Germany., Stöcklein S; Department of Radiology, University Hospital of Munich, LMU Munich, München, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany., Villemagne V; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Australia., Seibyl J; Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA., Sabri O; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Barthel H; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Perneczky R; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, München, Germany., Schöberl F; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany., Zwergal A; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; German Center for Vertigo and Balance Disorders (DSGZ), University Hospital of Munich, LMU Munich, München, Germany., Höglinger GU; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Levin J; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; Department of Neurology, University Hospital of Munich, LMU Munich, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany., Franzmeier N; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, München, Germany.; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; Department of Psychiatry and Neurochemistry, University of Gothenburg, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Mölndal and Gothenburg, Sweden., Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, München, Germany.; (SyNergy), Munich Cluster for Systems Neurology, München, Germany.; (DZNE), German Center for Neurodegenerative Diseases, München, Germany.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Oct; Vol. 20 (10), pp. 6896-6909. Date of Electronic Publication: 2024 Sep 12.

Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparison.

Autor: Gnörich J; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. Electronic address: Johannes.Gnoerich@med.uni-muenchen.de., Koehler M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Wind-Mark K; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Klaus C; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Zatcepin A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Palumbo G; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Lalia M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Monasor LS; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany; Graduate School of Systemic Neuroscience, LMU Munich, Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Eckenweber F; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Scheifele M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Gildehaus FJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., von Ungern-Sternberg B; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Barthel H; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany., Sabri O; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Herms J; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Center of Neuropathology and Prion Research, University of Munich, Munich Germany., Tahirovic S; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany., Franzmeier N; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Institute for Stroke and Dementia Research, LMU Munich, Munich, Germany., Ziegler S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany; Center of Neuropathology and Prion Research, University of Munich, Munich Germany. Electronic address: Matthias.Brendel@med.uni-muenchen.de.

Publikováno v: NeuroImage [Neuroimage] 2024 Aug 15; Vol. 297, pp. 120748. Date of Electronic Publication: 2024 Jul 26.

Additive value of [ ¹⁸ F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome.

Autor: Katzdobler S; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Nitschmann A; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Barthel H; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Bischof G; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.; Molecular Organization of the Brain, Institute for Neuroscience and Medicine, INM-2), Jülich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Marek K; InviCRO, LLC, Boston, MA, USA.; Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA., Song M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Wagemann O; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Palleis C; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Weidinger E; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Nack A; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Fietzek U; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Kurz C; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany., Häckert J; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, BKH Augsburg, Augsburg, Germany., Stapf T; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany., Ferschmann C; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Scheifele M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Eckenweber F; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Biechele G; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Franzmeier N; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Dewenter A; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Schönecker S; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Saur D; Department of Neurology, University of Leipzig Medical Center, Leipzig, Germany., Schroeter ML; Clinic for Cognitive Neurology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany., Rumpf JJ; Department of Neurology, University of Leipzig Medical Center, Leipzig, Germany., Rullmann M; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Schildan A; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Patt M; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Stephens AW; Life Molecular Imaging GmbH, Berlin, Germany., van Eimeren T; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany., Neumaier B; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.; Institute for Neuroscience and Medicine (INM-3), Cognitive Neuroscience, Research Centre Juelich, Juelich, Germany., Drzezga A; Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.; Molecular Organization of the Brain, Institute for Neuroscience and Medicine, INM-2), Jülich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany., Danek A; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Classen J; Department of Neurology, University of Leipzig Medical Center, Leipzig, Germany., Bürger K; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Janowitz D; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany., Rauchmann BS; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, BKH Augsburg, Augsburg, Germany.; Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany., Stöcklein S; Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany., Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, BKH Augsburg, Augsburg, Germany.; Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College, London, UK., Schöberl F; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Zwergal A; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Höglinger GU; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany., Bartenstein P; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany., Villemagne V; Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Seibyl J; InviCRO, LLC, Boston, MA, USA.; Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA., Sabri O; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Levin J; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. matthias.brendel@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. matthias.brendel@med.uni-muenchen.de.; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistraße 15, 81377, Munich, Germany. matthias.brendel@med.uni-muenchen.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jan; Vol. 50 (2), pp. 423-434. Date of Electronic Publication: 2022 Sep 14.

[ ¹⁸ F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.

Autor: Ballweg A; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Klaus C; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Vogler L; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Katzdobler S; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Wind K; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Zatcepin A; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Ziegler SI; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Secgin B; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Eckenweber F; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Bohr B; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Bernhardt A; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Fietzek U; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany., Rauchmann BS; Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, Munich, Germany., Stoecklein S; Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany., Quach S; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany., Beyer L; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Scheifele M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Simmet M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Joseph E; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Lindner S; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Berg I; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany., Koglin N; Life Molecular Imaging GmbH, Berlin, Germany., Mueller A; Life Molecular Imaging GmbH, Berlin, Germany., Stephens AW; Life Molecular Imaging GmbH, Berlin, Germany., Bartenstein P; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Tonn JC; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany., Albert NL; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Kümpfel T; Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany., Kerschensteiner M; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany.; Biomedical Center, Faculty of Medicine, LMU Munich, Munich, Germany., Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK., Levin J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Paeger L; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Herms J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany. matthias.brendel@med.uni-muenchen.de.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. matthias.brendel@med.uni-muenchen.de.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. matthias.brendel@med.uni-muenchen.de.

Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2023 Mar 11; Vol. 20 (1), pp. 68. Date of Electronic Publication: 2023 Mar 11.

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [ ¹⁸ F]-PI-2620 tau-PET signal.

Autor: Schönecker S; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Palleis C; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Franzmeier N; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Institute for Stroke and Dementia Research, Ludwig-Maximilians-Universität München, LMU München, Munich, Germany., Katzdobler S; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Ferschmann C; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Schuster S; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Finze A; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Scheifele M; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Prix C; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Fietzek U; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology and Clinical Neurophysiology, Schön Klinik München Schwabing, Munich, Germany., Weidinger E; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Nübling G; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Vöglein J; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Patt M; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Barthel H; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Sabri O; Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany., Danek A; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Höglinger GU; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; European Reference Network for Rare Neurological Diseases (ERN-RND), Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany., Brendel M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany., Levin J; Department of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; European Reference Network for Rare Neurological Diseases (ERN-RND), Munich, Germany. Electronic address: jlevin@med.uni-muenchen.de.

Publikováno v: NeuroImage. Clinical [Neuroimage Clin] 2023; Vol. 38, pp. 103402. Date of Electronic Publication: 2023 Apr 11.